M
Marco Valgimigli
Researcher at University of Bern
Publications - 772
Citations - 91095
Marco Valgimigli is an academic researcher from University of Bern. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 105, co-authored 696 publications receiving 69184 citations. Previous affiliations of Marco Valgimigli include University of Düsseldorf & Erasmus University Medical Center.
Papers
More filters
Journal ArticleDOI
Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention: Insights Into the STRATEGY Study
Gianluca Campo,Marco Valgimigli,Marco Valgimigli,Donato Gemmati,Gianfranco Percoco,Silvia Tognazzo,Giordano Cicchitelli,Linda Catozzi,Patrizia Malagutti,Maurizio Anselmi,Corrado Vassanelli,G. L. Scapoli,Roberto Ferrari +12 more
TL;DR: In this paper, the authors evaluated the value of platelet reactivity in predicting the response to treatment and outcome in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention assisted by glycoprotein IIb/IIIa inhibition.
Journal ArticleDOI
Prediction of 1-Year Clinical Outcomes Using the SYNTAX Score in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Scot Garg,Giovanna Sarno,Patrick W. Serruys,Alfredo Chapin Rodriguez,Leonardo Bolognese,Maurizio Anselmi,Nicoletta De Cesare,Salvatore Colangelo,Raúl Moreno,Stefania Gambetti,Monia Monti,Laura Bristot,Marco Bressers,Hector M. Garcia-Garcia,Parrinello Parrinello,Gianluca Campo,Marco Valgimigli +16 more
TL;DR: SXscore does have a role in the risk stratification of patients with STEMI having primary percutaneous coronary intervention; however, this ability can be improved through a combination with clinical variables.
Journal ArticleDOI
Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score
Vasim Farooq,Yvonne Vergouwe,Lorenz Räber,Pascal Vranckx,Hector M. Garcia-Garcia,Roberto Diletti,Arie Pieter Kappetein,Marie Angèle Morel,Ton de Vries,Michael Swart,Marco Valgimigli,Keith D. Dawkins,Stephan Windecker,Ewout W. Steyerberg,Patrick W. Serruys +14 more
TL;DR: The Logistic Clinical SXscore substantially enhances the prediction of 1-year mortality after PCI compared with the SXscore, and allows for an accurate personalized assessment of patient risk.
Journal ArticleDOI
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.
Giuseppe Andò,Bernardo Cortese,Filippo Russo,Martina Rothenbühler,Enrico Frigoli,Giuseppe Gargiulo,Carlo Briguori,Pascal Vranckx,Sergio Leonardi,Vincenzo Guiducci,Flavia Belloni,Fabio Ferrari,José M. de la Torre Hernández,Salvatore Curello,Francesco Liistro,Andrea Perkan,Stefano De Servi,Gavino Casu,Dellavalle A,Dionigi Fischetti,Antonio Micari,Bruno Loi,Fabio Mangiacapra,Nunzio Russo,Fabio Tarantino,Francesco Saia,Dik Heg,Stephan Windecker,Peter Jüni,Marco Valgimigli,Matrix Investigators +30 more
TL;DR: In ACS patients who underwent invasive management, RA was associated with a reduced risk of AKI compared with FA, and Stratified analyses suggested greater benefit with RA than FA in patients at greater risk for AKI.
Journal ArticleDOI
Drug-Eluting Stent for Left Main Coronary Artery Disease: The DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment
Alaide Chieffo,Emanuele Meliga,Azeem Latib,Seung-Jung Park,Yoshinobu Onuma,Piera Capranzano,Marco Valgimigli,Sanda Jegere,Raj Makkar,Igor F. Palacios,Young-Hak Kim,Paweł Buszman,Tarun Chakravarty,Imad Sheiban,Roxana Mehran,Christoph Naber,Ronan Margey,Arvind K. Agnihotri,Sebastiano Marra,Davide Capodanno,Martin B. Leon,Jeffrey W. Moses,Jean Fajadet,Thierry Lefèvre,Marie Claude Morice,Andrejs Erglis,Corrado Tamburino,Ottavio Alfieri,Patrick W. Serruys,Antonio Colombo +29 more
TL;DR: In a large all-comers registry, no difference was observed in the occurrence of death, cerebrovascular accidents, and MI between percutaneous coronary intervention with first-generation drug-eluting stents versus coronary artery bypass grafting (CABG) in unprotected left main coronary artery (ULMCA) stenosis.